Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cisatracurium besilate manufacturers

8 products found

Filters

8 products found

cisatracurium besilate

Vials, injection 2 mg/ml, 10 mg/ml - 5 ml, 10 ml, 20 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: Approved; US RLD / Holder: "Nimbex / Abbvie Inc"; Indication: Non-depolarizing skeletal neuromuscular blocking agent.
Manufacturer #8216

Manufacturer usually replies in 6 days

cisatracurium besilate

Solution for injection 10 mg/5 ml, 20 mg/10 ml, 200 mg/20 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
FDA
Manufacturer #13095

Manufacturer usually replies in 5 days

cisatracurium besilate

Vials 2 mg/ml - 5 ml, 10 ml, 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

cisatracurium besilate

Vials, injection 2 mg/ml - 2.5 ml, 5 ml, 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

cisatracurium besilate

Vials, injection 10 mg/5 ml, 20 mg/10 ml, 200 mg/20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #13095

Manufacturer usually replies in 5 days

cisatracurium besilate

Solution for injection 2 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #33693

Manufacturer usually replies in nan days

cisatracurium besilate

Powder for solution for injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

cisatracurium besilate

Injection 2 mg/ml, 10 mg/ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Cisatracurium Besilate Manufacturers

Cisatracurium is an injectable skeletal muscle relaxant that is nondepolarizing. Cisatracurium inhibits neuromuscular transmission by acting on neurotransmitter acetylcholine. Acetylcholinesterase inhibitors, such as neostigmine, block this function. Anticholinesterase medications quickly reverse the neuromuscular block caused by cisatracurium besylate once recovery has begun. The deeper the neuromuscular block at the moment of reversal, as with other non - depolarizing neuron blocking drugs, the longer it takes to regain neuromuscular function. Its onset and long - acting are intermediate when compared to other neuroleptic drugs.

How Does Cisatracurium Besilate Work?

Cisatracurium interacts with cholinergic synapses in motor end-plate cells in a competitive manner, preventing acetylcholine from reaching the receptors. The electrical impulse is not transmitted when cisatracurium binds to cholinergic receptors because it does not release ion channels, depolarizes the cell, or opens ion channels. Acetylcholinesterase inhibitors, including such neostigmine, block this function. Anticholinesterase medications quickly reverse the neuromuscular block caused by cisatracurium besylate once recovery has begun. Due to its quick breakdown at physiological pH, the interaction of cisatracurium to serum proteins has not been explored.

Wholesale Price of Cisatracurium Besilate

Regardless of the pharmacist you visit, cisatracurium intravenous solution (2 mg/mL) costs roughly $43 for a supply of 50 millilitres. Cisatracurium Besilate is available for sale from various Cisatracurium Besilate vendors at a range of costs. Its cost varies based on the location of origin, manufacturing businesses' wholesale expenses, supplier pricing, and other considerations. Pharmaceutical corporations generally support patient support programs. Cisatracurium Besilate suppliers, on the whole, are in favor of patient aid initiatives. The cost may vary among suppliers. It is also affected by a number of other things, such as the economy and market circumstances.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Cisatracurium Besilate offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Cisatracurium Besilate suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Cisatracurium Besilate. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, countries where Cisatracurium Besilate is already registered. Manufacturers also have special and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Cisatracurium Besilate suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Cisatracurium Besilate manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.